Long-term remissions after stopping pembrolizumab for relapsed or refractory multiple myeloma. Article uri icon

Overview

publication date

  • June 11, 2019

Research

keywords

  • Antibodies, Monoclonal, Humanized
  • Multiple Myeloma

Identity

PubMed Central ID

  • PMC6560349

Scopus Document Identifier

  • 85067489028

Digital Object Identifier (DOI)

  • 10.1182/bloodadvances.2019000191

PubMed ID

  • 31167817

Additional Document Info

volume

  • 3

issue

  • 11